These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32248249)

  • 21. Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.
    Demailly R; Escolano S; Quantin C; Tubert-Bitter P; Ahmed I
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1126-1134. PubMed ID: 28758270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015.
    Engeland A; Bjørge T; Klungsøyr K; Hjellvik V; Skurtveit S; Furu K
    Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):995-1004. PubMed ID: 29920833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescriptions filled during pregnancy for drugs with the potential of fetal harm.
    Kulaga S; Zargarzadeh AH; Bérard A
    BJOG; 2009 Dec; 116(13):1788-95. PubMed ID: 19832828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant dispensing trends in New Zealand between 2004 and 2007.
    Exeter D; Robinson E; Wheeler A
    Aust N Z J Psychiatry; 2009 Dec; 43(12):1131-40. PubMed ID: 20001412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Risk Medication Prescriptions in Primary Care for Women Without Documented Contraception.
    Panchal BD; Cash R; Moreno C; Vrontos E; Bourne C; Palmer S; Simpson A; Panchal AR
    J Am Board Fam Med; 2019; 32(4):474-480. PubMed ID: 31300567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is carbamazepine a human teratogen?
    Vajda FJE; O'Brien TJ; Graham J; Lander CM; Eadie MJ
    J Clin Neurosci; 2016 Jan; 23():34-37. PubMed ID: 26521756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in harmful drug exposure during pregnancy in France between 2013 and 2019: A nationwide cohort study.
    Louchet M; Collier M; Beeker N; Mandelbrot L; Sibiude J; Chouchana L; Treluyer JM
    PLoS One; 2024; 19(1):e0295897. PubMed ID: 38198446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescription Medication Use in Pregnancy in People with Disabilities: A Population-Based Cohort Study.
    Camden A; Grandi SM; Lunsky Y; Ray JG; Sharpe I; Lu H; Guttmann A; Tailor L; Vigod S; De Vera MA; Brown HK
    J Womens Health (Larchmt); 2024 Sep; 33(9):1224-1232. PubMed ID: 38946624
    [No Abstract]   [Full Text] [Related]  

  • 29. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
    Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
    Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets.
    Widnes SF; Schjøtt J; Eide GE; Granas AG
    Drug Saf; 2013 Jun; 36(6):481-9. PubMed ID: 23539202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy, prescription medicines and the potential risk of herb-drug interactions: a cross-sectional survey.
    McLay JS; Izzati N; Pallivalapila AR; Shetty A; Pande B; Rore C; Al Hail M; Stewart D
    BMC Complement Altern Med; 2017 Dec; 17(1):543. PubMed ID: 29258478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of medication use during pregnancy in mainland China: based on a national health insurance database in 2015.
    Zhang J; Ung COL; Guan X; Shi L
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):459. PubMed ID: 31795963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Misoprostol exposure during the first trimester of pregnancy: Is the malformation risk varying depending on the indication?
    Auffret M; Bernard-Phalippon N; Dekemp J; Carlier P; Gervoise Boyer M; Vial T; Gautier S
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():188-192. PubMed ID: 27865944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription opioid dispensing in Australian children and adolescents: a national population-based study.
    Bell J; Paget SP; Nielsen TC; Buckley NA; Collins J; Pearson SA; Nassar N
    Lancet Child Adolesc Health; 2019 Dec; 3(12):881-888. PubMed ID: 31604614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early pregnancy exposure to feto-toxic medications among out-patients in Malawi.
    Kabuluzi E; Campbell M; McGowan L; Chirwa E; Brabin L
    J Matern Fetal Neonatal Med; 2014 Aug; 27(12):1204-8. PubMed ID: 24168054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription retinoid and contraception use in women in Australia: A population-based study.
    Gerhardy L; Nassar N; Litchfield M; Kennedy D; Smith A; Gillies MB; Pearson SA; Zoega H; Shand A
    Australas J Dermatol; 2024 Aug; 65(5):428-436. PubMed ID: 38693687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of prescription medications with a potential for fetal harm among pregnant women.
    Andrade SE; Raebel MA; Morse AN; Davis RL; Chan KA; Finkelstein JA; Fortman KK; McPhillips H; Roblin D; Smith DH; Yood MU; Platt R; H Gurwitz J
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):546-54. PubMed ID: 16586470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database.
    Lacroix I; Hurault C; Sarramon MF; Guitard C; Berrebi A; Grau M; Albouy-Cossard C; Bourrel R; Elefant E; Montastruc JL; Damase-Michel C
    Eur J Clin Pharmacol; 2009 Aug; 65(8):839-46. PubMed ID: 19365629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.
    Engeland A; Bramness JG; Daltveit AK; Rønning M; Skurtveit S; Furu K
    Br J Clin Pharmacol; 2008 May; 65(5):653-60. PubMed ID: 18294334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women.
    Schwarz EB; Postlethwaite DA; Hung YY; Armstrong MA
    Ann Intern Med; 2007 Sep; 147(6):370-6. PubMed ID: 17876020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.